Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Human data available for anti-obesity drug PSN-602

Nov. 2, 2009

Everolimus/EC-MPS improves renal function in de novo renal transplant patients

Nov. 2, 2009

Phase III trial evaluates effects of tolvaptan on kidney volume change in ADPKD

Nov. 2, 2009

ADL-5510 reduces levodopa-induced dyskinesia in macaque model of PD

Nov. 2, 2009

CP-8947, a novel nonsteroidal SPRM, exhibits progestational activity in preclinical study

Nov. 2, 2009

12-month COMET-1 results show efficacy of CRx-102 in knee osteoarthritis

Nov. 2, 2009

In vivo profile of K-056, a new adenosine A2A antagonist

Nov. 2, 2009

INK-055 shows promise in mouse model of collagen-induced arthritis

Oct. 30, 2009

RaQualia Pharma reports on novel TRPM8 antagonists as analgesic candidates

Oct. 30, 2009

Yuhan Research Institute discovers glucokinase activator with antidiabetes potential

Oct. 30, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...